Description

PT-141, also known as bremelanotide a medication used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. It is a synthetic peptide that works by activating melanocortin receptors in the brain to increase sexual desire and arousal, unlike traditional erectile dysfunction (ED) drugs that focus on blood flow.
Key Information.
Mechanism of Action: PT-141 targets the central nervous system, specifically the hypothalamus, to modulate the brain pathways involved in sexual desire and arousal. It increases dopamine activity, which plays a critical role in sexual drive and reward pathways.